Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

RiboGene receives further funding for HCV

Oct. 18, 1996

Joint venture to develop Exten's artificial liver technology

Oct. 18, 1996

Tokyo Tanabe discloses agents for the treatment of diarrhea

Oct. 18, 1996

LTA4 hydrolase inhibitor effective in ulcerative colitis

Oct. 18, 1996

Astra-CSL collaboration for H. pylori immunotherapeutic

Oct. 18, 1996

Gastric antisecretory agents disclosed by Il-Yang

Oct. 18, 1996

Yamanouchi reports on GI drugs in development

Oct. 11, 1996

Gastrointestinal drugs in the pipeline at Fujisawa

Oct. 11, 1996

Axcan acquires enzyme preparation for pancreatic insufficiency

Oct. 11, 1996

Promising results from U.S. trial on Zadaxin for hepatitis C

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...